Abnormal first-trimester ductus venosus blood flow: A marker of cardiac defects in fetuses with normal karyotype and nuchal translucency

Ultrasound in Obstetrics and Gynecology

Volumn 35, Issue 3, 2010, Pages 267-272

  Martinez J M ^a   Comas, M ^a   Borrell, A ^a   Bennasar, M ^a   Gomez O ^a   Puerto, B ^a   Gratacos E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Congenital heart defects; Doppler ultrasound; Ductus venosus; First trimester screening

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; FETUS HEART; FIRST TRIMESTER PREGNANCY; GENETICS; GESTATIONAL AGE; HUMAN; INFERIOR CAVA VEIN; METHODOLOGY; NUCHAL TRANSLUCENCY MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PREGNANCY; PROSPECTIVE STUDY; UMBILICAL VEIN;

ADULT; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; FEMALE; FETAL HEART; GESTATIONAL AGE; HEART DEFECTS, CONGENITAL; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; ULTRASONOGRAPHY, PRENATAL; UMBILICAL VEINS; VENA CAVA, INFERIOR;

EID: 77949591739     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.7544     Document Type: Article

References (35)

1. Mitchell SC, Korones SB. Congenital heart disease in 56109 births. Incidence and natural history. Circulation 1971; 43: 323-333.
2. Yang Q, Khoury M, Mannino D. Trends and patterns of mortality associated with birth defects and genetics diseases in the United States, 1979-1992: an analysis of multi-cause mortality data. Genet Epidemiol 1997; 14: 493-505.
3. Sharland G. Routine fetal cardiac screening: what are we doing and what should we do? Prenat Diagn 2004; 24: 1123-1129.
4. Yates RS. The influence of prenatal diagnosis on postnatal outcome in patients with structural congenital heart disease. Prenat Diagn 2004; 24: 1143-1149.
5. Allan L. Prenatal diagnosis of structural cardiac defects. Am J Med Genet 2007; 145: 73-76.
6. Garne E, Stoll C, Clementi M; Euroscan Group. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001; 17: 386-391.
7. Comas C, Galindo A, Martinez JM, Carrera JM, Gutierrez L, Puerto B, Borrell A. Early prenatal diagnosis of major cardiac anomalies in a high-risk population. Prenat Diagn 2002; 22: 586-593.
8. Galindo A, Comas C, Martinez JM, Gutierrez L, Carrera JM, Puerto B, Borrell A, Mortera C. Cardiac defects in chromo-somally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation. J Maternal Fetal Neonatal Med 2003;13: 163-170.
9. Rasiah SV, Publicover M, Ewer AK, Khan KS, Kilby MD, Zamora J. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol 2006; 28: 110-116.
10. Allan LD. Echocardiographic detection of congenital heart disease in the fetuses: present and future. Br Heart J 1995; 74: 103-106.
11. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10 -14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81-85.
12. Makrydimas G, Sotiriadis A, Ioannidis JPA. Screening performance of first-trimester nuchal translucency for major cardiac defects: A meta-analysis. Am J Obstet Gynecol 2003; 189: 1330-1335.
13. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 10 -14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 12: 380-384.
14. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307-310.
15. Borrell A. The ductus venosus in early pregnancy and congenital anomalies. Prenat Diagn 2004; 24: 688-692.
16. Favre R, Cherif Y, Kohler M, Kohler A, Hunsinger MC, Bouffet N, Tanghe M, Cancellier M, Nisand I. The role of fetal nuchal translucency and ductus venosus Doppler at 11 -14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol 2003; 21: 239-243.
17. Bilardo CM, Müller MA, Zikulnig I, Schipper M, Hecher K. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001; 17: 288-294.
18. Toyama JM, Brizot MI, Liao AW, Lopes IM, Nomura RMY, Saldanha FAT, Zugaib M. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome. Ultrasound Obstet Gynecol 2004; 23: 341 -345.
19. Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2008; 31: 256-260.
20. Atzei A, Gajewska K, Huggon C, Allan L, Nicolaides KH. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005; 26: 154-157.
21. Oh C, Harman C, Baschat AA. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency. Ultrasound Obstet Gynecol 2007; 30: 192-196.
22. Maiz N, Valencia C, Emmanuel E, Staboulidou I, Nicolaides KH. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13 + 6 weeks of gestation. Obstet Gynecol 2008; 112: 598-605.
23. Borrell A, Gonce A, Martinez JM, Borobio V, Fortuny A, Coll O, Cuckle H. First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers. Prenat Diagn 2005; 25: 901-905.
24. Borrell A, Quinto L, Fortuny A, Borobio V, Mercadé I, Vanrell JA. Translucencia nucal y ductus venoso: Valores de referencia en el primer trimestre de la gestación. Prog Obstet Ginecol 2006; 49: 434-440.
25. Campbell S, Platt J. The publishing of papers on first-trimester Doppler. Ultrasound Obstet Gynecol 1999; 14: 159-160.
26. Martinez JM, Gómez O, del Rio M, Puerto B, Borrell A, Cararach V, Fortuny A. Early fetal echocardiography: a new challenge in prenatal diagnosis. Ultrasound Rev Obstet Gynecol 2002; 4: 251-260.
27. Comas C, Torrents M, Muñoz A, Antolin E, Figueras F, Echevarria M. Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker? Obstet Gynecol 2002; 100: 648-654.
28. Haak MC, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM. Ductus venosus flow velocities in relation to the cardiac defects in first-trimester fetuses with enlarged nuchal translucency. Am J Obstet Gynecol 2003; 188: 727-733.
29. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-268.
30. Souka AP, Kaisenberg CS, Hyett JA, Sones JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192: 1005-1021.
31. Simpson LL, Malone FD, Bianchi DW, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, D'Alton ME. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol 2007; 109: 376-383.
32. Gembruch U, Meise C, Germer U, Berg C, Geipel A. Venous Doppler ultrasound in 146 fetuses with congenital heart disease. Ultrasound Obstet Gynecol 2003; 22: 345-350.
33. Hung JH, Fu CH, Lu J, Hung C. Ductus venosus blood flow resistance and congenital heart defects in the second trimester. JClin Ultrasound 2008; 36: 72-78.
34. Borrell A, Perez M, Figueras F, Meler E, Gonce A, Gratacos E. Reliability analysis on ductus venosus assessment at 11-14 weeks' gestation in a high-risk population. Prenat Diagn 2007; 27: 442-446.
35. Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH. Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2008; 31: 503-506.